ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,031 | -69.7% | 12,628 | -52.5% | 0.02% | -67.7% |
Q2 2023 | $132,127 | -19.3% | 26,585 | -19.8% | 0.06% | -45.6% |
Q1 2023 | $163,761 | -23.7% | 33,150 | -2.8% | 0.11% | -35.6% |
Q4 2022 | $214,539 | -12.4% | 34,108 | +50.1% | 0.18% | -40.8% |
Q3 2022 | $245,000 | -37.3% | 22,716 | -33.8% | 0.30% | -19.0% |
Q2 2022 | $391,000 | +92.6% | 34,336 | +54.0% | 0.37% | +319.3% |
Q1 2022 | $203,000 | -48.3% | 22,296 | -15.4% | 0.09% | -49.4% |
Q4 2021 | $393,000 | – | 26,341 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |